Cargando…
Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2
As of April 9, 2020, a novel coronavirus (SARS‐CoV‐2) had caused 89,931 deaths and 1,503,900 confirmed cases worldwide, which indicates an increasingly severe and uncontrollable situation. Initially, little was known about the virus. As research continues, we now know the genome structure, epidemiol...
Autores principales: | Zhou, Hong, Fang, Yan, Xu, Tao, Ni, Wei‐Jian, Shen, Ai‐Zong, Meng, Xiao‐Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267399/ https://www.ncbi.nlm.nih.gov/pubmed/32368792 http://dx.doi.org/10.1111/bph.15092 |
Ejemplares similares
-
Possible therapeutic targets and promising drugs based on unsymmetrical hetaryl-substituted porphyrins to combat SARS-CoV-2
por: Gubarev, Yury A., et al.
Publicado: (2021) -
Nanosponges: An overlooked promising strategy to combat SARS-CoV-2
por: Mostafavi, Ebrahim, et al.
Publicado: (2022) -
Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era
por: Saini, Jasleen, et al.
Publicado: (2022) -
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements
por: Pandey, Abhjieet, et al.
Publicado: (2020) -
Perspectives on Repurposed Drugs Based on Globally Accepted Therapeutic Guidelines to Combat SARS-CoV-2 Infection
por: Rosalia, Rina
Publicado: (2021)